Aldevron, Minaris Expand Cell Therapy Supply Pact
PHILADELPHIA, PA — Aldevron, a unit of Danaher Corporation (NYSE: DHR), and Minaris expanded a licensing agreement tied to lentiviral plasmid manufacturing, deepening a partnership aimed at accelerating development timelines …
Aldevron, Minaris Expand Cell Therapy Supply Pact Read More